Mazarguil H - Search Results

1

Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists.

Mollereau C, Mazarguil H, Marcus D, Quelven I, Kotani M, Lannoy V, Dumont Y, Quirion R, Detheux M, Parmentier M, Zajac JM. Mollereau C, et al. Among authors: mazarguil h. Eur J Pharmacol. 2002 Sep 20;451(3):245-56. doi: 10.1016/s0014-2999(02)02224-0. Eur J Pharmacol. 2002. PMID: 12242085

2

Characterization of two novel tritiated radioligands for labelling Neuropeptide FF (NPFF(1) and NPFF(2)) receptors.

Talmont F, Garcia LP, Mazarguil H, Zajac JM, Mollereau C. Talmont F, et al. Among authors: mazarguil h. Neurochem Int. 2009 Dec;55(8):815-9. doi: 10.1016/j.neuint.2009.08.004. Epub 2009 Aug 12. Neurochem Int. 2009. PMID: 19682524

3

Study of the N-terminal part of peptidic selective NPFF₂ agonists.

Mazarguil H, Mollereau C, Czaplicki G, Zajac JM. Mazarguil H, et al. Peptides. 2012 Sep;37(1):157-60. doi: 10.1016/j.peptides.2012.07.008. Epub 2012 Jul 16. Peptides. 2012. PMID: 22813580

4

Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs.

Quelven I, Roussin A, Burlet-Schiltz O, Gouardères C, Tafani JA, Mazarguil H, Zajac JM. Quelven I, et al. Among authors: mazarguil h. Eur J Pharmacol. 2002 Aug 2;449(1-2):91-8. doi: 10.1016/s0014-2999(02)01983-0. Eur J Pharmacol. 2002. PMID: 12163111

5

Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells.

Mollereau C, Mazarguil H, Zajac JM, Roumy M. Mollereau C, et al. Among authors: mazarguil h. Mol Pharmacol. 2005 Mar;67(3):965-75. doi: 10.1124/mol.104.004614. Epub 2004 Dec 17. Mol Pharmacol. 2005. PMID: 15608144

6

Functional characterization of a human receptor for neuropeptide FF and related peptides.

Kotani M, Mollereau C, Detheux M, Le Poul E, Brézillon S, Vakili J, Mazarguil H, Vassart G, Zajac JM, Parmentier M. Kotani M, et al. Among authors: mazarguil h. Br J Pharmacol. 2001 May;133(1):138-44. doi: 10.1038/sj.bjp.0704038. Br J Pharmacol. 2001. PMID: 11325803 Free PMC article.

7

Structure-activity relationships of neuropeptide FF: role of C-terminal regions.

Mazarguil H, Gouardères C, Tafani JA, Marcus D, Kotani M, Mollereau C, Roumy M, Zajac JM. Mazarguil H, et al. Peptides. 2001 Sep;22(9):1471-8. doi: 10.1016/s0196-9781(01)00468-5. Peptides. 2001. PMID: 11514031

8

Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [(125I]EYF as selective radioligands.

Gouardères C, Quelven I, Mollereau C, Mazarguil H, Rice SQ, Zajac JM. Gouardères C, et al. Among authors: mazarguil h. Neuroscience. 2002;115(2):349-61. doi: 10.1016/s0306-4522(02)00419-0. Neuroscience. 2002. PMID: 12421602

9

Anti-analgesia of a selective NPFF2 agonist depends on opioid activity.

Roussin A, Serre F, Gouardères C, Mazarguil H, Roumy M, Mollereau C, Zajac JM. Roussin A, et al. Among authors: mazarguil h. Biochem Biophys Res Commun. 2005 Oct 14;336(1):197-203. doi: 10.1016/j.bbrc.2005.08.060. Biochem Biophys Res Commun. 2005. PMID: 16129413

10

Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects.

Gicquel S, Mazarguil H, Allard M, Simonnet G, Zajac JM. Gicquel S, et al. Among authors: mazarguil h. Eur J Pharmacol. 1992 Nov 3;222(1):61-7. doi: 10.1016/0014-2999(92)90463-e. Eur J Pharmacol. 1992. PMID: 1468500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters